NEW YORK (GenomeWeb News) — The University of Arkansas for Medical Sciences has received a $4.5 million endowment to establish a lab to conduct genomic and proteomic studies of multiple myeloma, or cancer of the bone marrow, the school said today.
The commitment from Stephen and Nancy Grand to the university’s Myeloma Institute for Research and Therapy will be used to establish a mass-spectrometry lab to analyze proteins that are produced by myeloma tumor cells and bone marrow cells.
Stephen Grand, a patient at the Myeloma Institute since 2006, also donated $300,000 last year with his wife to help the institute develop ellipticine, a plant-derived alkaloid that is a potential therapeutic agent.
The school said the studies “are expected to clarify key disease mechanisms and details about myeloma that will be translated into clinical care.”
The new lab, called the Nancy and Stephen Grand Laboratory for Myeloma Proteomics, will be headed by Ricky Edmondson. It will be located at UAMS’ Arkansas Cancer Research Center, located in Little Rock.